The Coronary Angiography Devices Market is expected to reach USD 11.96 Billion by 2030 at 6.20% CAGR during the forecast period 2022-2030.
Coronary angiography is a minimally invasive procedure that uses a contrast material and x-rays to study and observe the blood flow through the arteries in the heart. The growing prevalence of cardiovascular diseases, increasing numbers of coronary angiography procedures, and growing geriatric population are major drivers propelling the market growth.
Canon Medical, on August 7th, 2023, announced the commercial release of its angiography system Alphenix/Evolve Edition for sale on the European market. It is a deep learning-powered real-time system that improves imaging while reducing procedure duration and radiation dose in routine and complex percutaneous coronary intervention (PCI) procedures or percutaneous structural heart disease interventions.
According to Canon Medical Systems USA, Incorporation, In February 2023, it released its newest angiography system, Aplio i900. An exceptional angiography machine having a high-performance rating, which is fit for various clinical settings that include interventional radiology suites and vascular surgery departments.
GE Healthcare launched the ‘Discovery IG 740 mobile angiography system’ latest product in April 2022. The untethered Discovery IGS 740 provides outstanding room design and sitting flexibility. Superior comfort and control can be achieved by means of Discovery’s rail-less design and flexible wide-bore C-arm positioning. Additionally, its large detector accommodates even larger anatomies in both 2D and 3D.
The new Siemens Healthineers Artis icono angiography system was set in motion in March 2023. And is considered a small portable device for performing Angioplasty of small blood vessels, making it ideal for use in mobile cath labs or remote health centers.
Royal Philips announced its vision for interventional medicine by integrating groundbreaking spectral CT imaging technology into a hybrid Angio CT suite in November 2021. By merging their unique Spectral CT7500 System with Image-Guided Therapy System – Azurion with FlexArm within one Interventional Suite solution, Philips hopes to give interventionalists instant access to these two important imaging modalities at point-of-care.
In December 2020, GE Healthcare introduced the Allia IGS7 system that uses AI-optimized dose & imaging settings, enabling easier access to rotational angio.
In March 2020, Kinepict Health received FDA 510(k) clearance for Kinepict Medical Imaging Tool (KMIT) software, which utilizes Digital Variance Angiography (DVA).
According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. Moreover, increasing research and development and consequent product launches by various prominent players are likely to fuel the market growth during the forecast period. For instance, in February 2017, Medtronic received FDA approval for its DxTerity diagnostic angiography catheter line. Furthermore, increasing number of patients suffering from diabetes and obesity, lead to the increase in the prevalence of cardiovascular diseases which is likely to contribute to the growth of the market.
Despite the drivers, the high cost of coronary angiography and poor reimbursement policies in some developing economies are likely to restrain the market growth.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the coronary angiography devices market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others
Industry News
In 2021, Boston Scientific launched the Synergy XD everolimus-eluting platinum chromium coronary stent system to treat patients with coronary artery disease.
In 2020, Philips partnered with Medtronic on the development and commercialization of a variety of innovative image-guided therapy solutions for heart arrhythmia treatment.
In 2020 Canon Medical Systems announced the launch of Aquilion ONE / PRISM Edition CT system that is able to produce fast and accurate images of the heart and other organs.
Royal Philips introduced its vision for interventional medicine in November 2021 by integrating its revolutionary spectral CT imaging technology into a hybrid Angio CT suite. By combining it with their Azurion Image-Guided Therapy System – FlexArm, and their Spectral CT 7500 platform, Philip will look to give both types of imaging modalities immediate tableside access for interventionalists through a single interventional suite solution.
Siemens Healthineers launched the "Mobilett Impact" wireless mobile X-ray system in July 2022, enabling bedside scans for patients' conditions, hence increasing convenience during procedures.
Canon Medical joined hands with Cleerly in July 2022 to tackle heart diseases. What makes this alliance unique is that it combines Cleerly's digital pathway solution for the analysis of coronary artery disease and Canon's AI-powered CT technology.
GE Healthcare has released Allia IGS 7 systems in December 2020 which enables AI optimised dosage imaging settings and also facilitates use of rotational angiography.
Kinepict Health received the FDA (Federal Drug Administration) 's (510k) clearance for KMIT software (Kinepict Medical Imaging Tool), which uses Digital Variance Angiography (DVA) as of March 2020.
The latest product from GE Healthcare came out in April 2022. The product, Untethered Discovery IGS 740 provides amazing room design and seating flexibility. Its rail-free design with flexible wide-bore C-arm positioning allows users to practice exceptional comfort and control with Discovery IGS 740. It also has a large detector that covers large anatomies (both 2D and 3D).
The coronary angiography devices market is segmented on the basis of product, devices, procedures, technology, indication, application, and end-user.
On the basis of product, the market is classified into angiography systems, angiography catheters, angiography contrast media, Vascular Closure Devices (VCDs), angiography balloons, angiography Guidewires, and angiography accessories.
The coronary angiography devices market on the basis of devices is segmented into Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), conventional angiography, Digital Subtraction Angiography (DSA), Catheter angiography, coronary angiography, and others.
On the basis of the procedure, the market is segmented as coronary angiography, endovascular angiography, peripheral vascular angiography, and other angiography procedures.
On the basis of technology, the market is segmented into X-ray angiography, CT angiography, MR angiography, and other angiography technologies.
On the basis of indication, the coronary angiography devices market is segmented into coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and other indications.
The coronary angiography devices market on the basis of application is segmented into diagnostics and therapeutics.
On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic and imaging centers, and research institutes.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas coronary angiography devices market is further segmented into North America, and South America. North America is further classified as the U.S. and Canada.
The Europe coronary angiography devices market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific coronary angiography devices market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle East & Africa coronary angiography devices market is segmented into the Middle East and Africa.
Regional Market Summary
The Americas are likely to dominate the coronary angiography devices market owing to the well-established healthcare sector, increasing the prevalence of cardiovascular diseases and availability of advanced technology. According to the American Heart Association data, in 2017, about 92.1 million American population are living with some form of cardiovascular disease or the after-effects of stroke. Moreover, increasing geriatric population, growing awareness about benefits of early diagnosis and treatment of heart disorder are has fueled the market growth in this region. For instance, according to the Population Reference Bureau, the number of Americans aged over 65 is projected to be more than double from 46 million in 2014 to over 98 million by 2060.
Europe is likely to hold the second position in the coronary angiography devices market. It is expected that the rising demand for medical diagnostic techniques and increasing prevalence of cardiovascular diseases in this region are likely to drive the market. For instance, according to the European Cardiovascular Diseases Statistics, in 2015, an approximate of 85 million people were living with cardiovascular diseases in Europe and about 49 million people with the disease in the European Union.
Asia Pacific is the fastest growing region in the market owing to the huge patient population with heart diseases and rising geriatric population. For instance, according to the WHO, 2015, Asia's elderly population is projected to reach nearly 923 million by 2050. Moreover, government participation for improvement of the healthcare sector in India and Japan are likely to contribute to the market growth.
The Middle East and Africa account for the lowest market share in the coronary angiography devices market. The Middle East holds the major share in the market in this region owing to a well-developed economy, whereas, African region is expected to grow due to the rising awareness about coronary artery diseases.
Some of the key players in the coronary angiography devices market are
Intended Audience
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 11.96 Billion |
| Â Â CAGR | Â Â 6.20% |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2022-2030 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Product, Devices, Procedures, Technology, Indication, Application, and End-user |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Terumo Medical Corporation, Boston Scientific Corporation, Canon Medical Systems, Cordis (A Cardinal Health Company), Braun Melsungen AG, Angiodynamics, Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Shimadzu Corporation, Siemens Healthcare |
| Â Â Key Market Opportunities | Â Â New product launches and R&D Amongst major key Players |
| Â Â Key Market Drivers | Â Â Increasing number of patients suffering from diabetes and obesity, lead to the increase in the prevalence of cardiovascular diseases |
Frequently Asked Questions (FAQ) :
The coronary angiography devices market can grow with a CAGR of 6.20% during the forecast period of 2022-2030.
The high cost of the procedure and poor reimbursement policies can deter the coronary angiography devices market growth.
Associated industries like diagnostic & imaging centers, hospitals & clinics, and research institutes would drive the global coronary angiography devices market.
The Americas would drive the global coronary angiography devices market growth.
The Asia Pacific market has the opportunity to be the fastest coronary angiography device market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
